Lundbeck
HLUN-B.CO
#2442
Rank
$6.04 B
Marketcap
$6.33
Share price
0.62%
Change (1 day)
30.69%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Operating Margin for Lundbeck (HLUN-B.CO)

Operating Margin as of November 2024 (TTM): 15.75%

According to Lundbeck 's latest financial reports and stock price the company's current Operating Margin is 15.75%. At the end of 2023 the company had an Operating Margin of 15.03%.

Operating Margin history for Lundbeck from 2009 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202315.03%10.86%
202213.56%39.79%
20219.70%-10.06%
202010.79%-38.13%
201917.43%-41.08%
201829.59%19.59%
201724.74%79.33%
201613.80%-128.74%
2015-48.01%11445.45%
2014-0.42%-104.31%
20139.65%-14.03%
201211.22%-45.52%
201120.60%-7.53%
201022.28%14.86%
200919.39%-1.7%
200819.73%-15.39%
200723.32%31.69%
200617.71%-28.36%
200524.72%-4.58%
200425.90%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.